Impactful Connections and Intelligence
The global biopharmaceutical industry's one-stop shop of market intelligence and business connections.
0
Connections
0
Conventions
0
Clients
0
Countries
0
Children Sent to School
Explore Our Services
B2B EVENTS
Thought leadership, industry knowledge-sharing and quality networking are at the core of IMAPAC's B2B events.
MARKET INTELLIGENCE
Data-driven decisions to help organizations grow. In-depth B2B biopharmaceutical industry intelligence brought to you by our team of analysts; fully customizable to your requirements.
DIGITAL MARKETING
Expand your influence, be it through branding & display ads, content creation or thought leadership.
Latest News
July 26, 2022
Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine
Excerpt Primary vaccination with Beta-containing vaccine candidate delivers 64.7% efficacy against symptomatic infection in adults, and 75.1% efficacy in participants previously infected with COVID-19Article Summary Sequencing analysis has shown 72 percent efficacy against Omicron in adults overall and 93.2 percent in seropositives. Favorable safety and tolerability profile First-ever efficacy findings in an Omicron setting indicate […]
LOTTE BIOLOGICS Signs MoU with MilliporeSigma for Strategic Partnership
Excerpt Lotte Group has named MilliporeSigma as its preferred bioprocess vendor to support its burgeoning US-based CDMO business. Article Summary LOTTE BIOLOGICS, new biologics business of LOTTE group, signed a Memorandum of Understanding (MoU) with MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, outlining […]
July 26, 2022
BioNTech Starts Construction of First mRNA Vaccine Manufacturing Facility in Africa
Excerpt The first container modules are expected to be delivered by the end of 2022 from Kigali, Rwanda, the site of BioNTech’s first African modular mRNA manufacturing factory. The facility will come with two BioNTainers initially, and it is anticipated that by 2024, there will be roughly 100 employees working there. BioNTech’s malaria vaccine candidates […]
July 26, 2022
WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapore
Excerpt A cutting-edge, fully integrated CRDMO center of WuXi Biologics will be developed in Singapore, including a large-scale drug substance and drug product manufacturing facility. Article Summary With a 10-year investment plan worth USD$1.4 billion (S$2 billion), WuXi Biologics, a global leader in Contract Research, Development and Manufacturing (CRDMO), will expand its research, development, and […]
July 26, 2022
Hear from Our Clients
Thank you again for producing this really successful and relevant conference. I enjoyed expert conversations with outstanding people and network opportunities were excellent.
Samsung Engineering
South Korea
Excellent event with good knowledge sharing by experienced scientists globally to combat present situation and challenges faced by the vaccine manufacturing industry. Kind hospitality by IMAPAC...Keep it up.
Hester Biosciences Limited
India
Talks were very interesting addressing subjects really important such as the balance of Th1 and Th2 cells as immune response of COVID-19 vaccines. I have achieved a lot watching and rewatching the videos too.
Instituto Butantan
Brazil
It’s my pleasure to be a participant in IMAPAC's 11th World Vaccine summit. This virtual platform supported in exploring more on the current trends on vaccine developments from various manufacturers/ research centers.
BravoVax
China
